Similar articles

• Biotechs sue Columbia over fourth Axel patent.

  Howard K. Howard K. Nat Biotechnol. 2003 Sep;21(9):955-6. doi: 10.1038/nbt0903-955. Nat Biotechnol. 2003. PMID: 12949538 No abstract available.
• US court case to define EST patentability.

  Lawrence S. Lawrence S. Nat Biotechnol. 2005 May;23(5):513. doi: 10.1038/nbt0505-513. Nat Biotechnol. 2005. PMID: 15877055 No abstract available.
• Napster case spills into biotech sector.

  Bouchie A. Bouchie A. Nat Biotechnol. 2004 Sep;22(9):1185-6. Nat Biotechnol. 2004. PMID: 15384189 No abstract available.
• Patenting pluripotence: the next battle for stem cell intellectual property.

  Vrtovec KT, Scott CT. Vrtovec KT, et al. Nat Biotechnol. 2008 Apr;26(4):393-5. doi: 10.1038/nbt0408-393. Nat Biotechnol. 2008. PMID: 18392018 Review.
• Patents, biotechnology, and hematologic pathology.

  Kettelberger DM, Gambrell P, McClung G. Kettelberger DM, et al. Hematol Pathol. 1992;6(2):99-104. Hematol Pathol. 1992. PMID: 1607346 Review. No abstract available.